6,821,513, relating to methods of stimulating blood production in patients with deficient stem cells...Proteonomix Inc., of Hawthorne, N.J., reported preclinical research demonstrating the ability of combinations of approved drugs to mobilize mesenchymal stem cells to peripheral blood circulation in animal models, including mice, rats and nonhuman primates

iPierian said it will focus drug discovery programs exclusively on neurodegenerative disease, based on its research in disease modeling of patient-derived induced pluripotent stem cells

It's the second collaboration between Fibrocell and UCLA and, as part of the existing collaboration, UCLA researchers used Fibrocell's technology to discover rare stem cells and cell types with regenerative properties within adult human skin

IntegraMed is required to gain regulatory approval for the sale of Travelan in those countries, and to sell specific minimum volumes...CureXcell is designed to work by replenishing the imbalanced inflammatory environment in nonhealing wounds with a broad array of functionally active allogeneic immune cells

International Stem Cell Corp., of Carlsbad, Calif., reported data from preclinical programs, showing in vivo that the application of A9 dopaminergic neurons derived from human parthenogenetic stem cells (hpSC) could be used to develop a treatment for Parkinson's disease

In other news, Gentium said it received the Day 180 list of outstanding issues from the European Committee for Medicinal Products for Human Use in connection with the marketing authorization application for Defibrotide to treat and prevent hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation therapy

Gentium SpA, of Villa Guardia, Italy, said it received the Day 180 list of outstanding issues from the European Committee for Medicinal Products for Human Use in connection with the marketing authorization application for Defibrotide to treat and prevent hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation therapy

Fibrocell Science Inc., of Exton, Pa., and researchers at the University of California, Los Angeles, identified two adult stem cell-like subpopulations in adult human skin

The system developed by Kadimastem enables the use of human functional tissues produced industrially from pluripotent stem cells to search for potential new drugs

The system developed by Kadimastem enables the use of human functional tissues produced industrially from pluripotent stem cells to search for potential new drugs

Results showed an injection of the stem cells in neonatal MPS-1 mice reduced the accumulation of glycosaminoglycans in the brain, resulting in improvements in behavioral and motor function in diseased mice

The treatment encompasses a way of cell culturing and includes a medical device designed for re-transplantation of an individual's own stem cells into the disc area for repair

IntelliCell BioSciences Inc., of New York, inked a technology licensing agreement with Stem Cells 21, of Thailand, a cellular treatment business, to advance adult autologous vascular cellular therapy in Thailand

The two companies will begin a Phase III trial of TransVax for hematopoietic stem cell transplant recipients in the second half of this year, and a Phase II trial in solid organ transplant shortly thereafter

The two companies will begin a Phase III trial of TransVax for hematopoietic stem cell transplant recipients in the second half of this year, and a Phase II trial in solid organ transplant shortly thereafter

In other news, Addex reported top-line data showing that a Phase IIa trial testing dipraglurant, a small-molecule allosteric modulator, in Parkinson's disease patients suffering from debilitating levodopa-induced dyskinesia (LID) met its primary endpoint, with the drug exhibiting a good safety and tolerability profile...In other news, AstraZeneca said subanalysis data from its VOYAGER study suggested that achieving an LDL-C goal of less than 70 mg/dL or a greater than 50 percent reduction in LDL-C

The work focused on mesenchymal stem cells, and the results showed the ability to determine cells by gyclosylation profiles that predict tumorgenicity and predict differentiation potential...The research is aimed at developing a platform that will significantly improve the ability to identify and develop stem cells for transplant and treatment

VistaGen Therapeutics Inc., of South San Francisco, inked a research collaboration with Duke University, with the initial goal of exploring potential development of engineered, stem cell-derived cardiac tissues to expand the scope of VistaGen's drug rescue capabilities focused on heart toxicity

Cellartis will collaborate with academic partners to generate human induced pluripotent stem cell lines from DILI- and non-DILI-sensitive individuals that can be characterized, expanded and banked to generate hepatocytes for the project...In other news, Gentium said a Phase III trial evaluating defibrotide in preventing hepatic veno-occlusive disease (VOD) in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) showed that use of defibrotide led to a 40 percent reduction in